Evaluation of the current situation and rationality of electronic prescription in retail pharmacies in Chengdu in the context of “Internet + drug circulation”_Chinese Journal of Evidence-Based Medicine

Authors：

WANG Jing ^1,2 , XIAO Guirong ³ , SUN Guorui ⁴ ,  HUANG Zhen ⁴ ,  HU Ming ¹

1. West China School of Pharmacy, Sichuan University, Chengdu 610041, P.R.China;
2. Clinical Research Institute, the Affiliated Hospital of Southwest Medical University, Luzhou 646000, P.R.China;
3. West China Hospital, Sichuan University, Chengdu 610041, P.R.China;
4. Market Supervision Administration of Chengdu Municipality, Chengdu 610041, P.R.China;

Corresponding?author：

HUANG Zhen, Email: 723305213@qq.com; HU Ming, Email: huming@scu.edu.cn

Keywords：

Retail pharmacies; Electronic prescriptions; Rational drug use

DOI：

10.7507/1672-2531.202006132

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objectives To evaluate the current situation and rationality of electronic prescription in retail pharmacies in Chengdu, so as to provide references for further improving the sales of prescription drugs in retail drugstores and the level of rational drug use.Methods A set of evaluation index system was constructed, and a prescription review group was set up. Eventually, 7 200 sample electronic prescriptions were collected for retrospective analysis and evaluation.Results Prescriptions from private medical institutions constituted the majority (3 543, 49.21%), and the majority of patients were junior and middle-aged, primarily respiratory diseases (38.24%) and circulatory diseases (17.11%), etc. The average quantity of drugs was 1.60 per prescription, percentage of antimicrobial use was 65.25%, percentage of essential medicines used was 34.92%, and reasonable rate of prescription was 95.21%.Conclusions Electronic prescription services mode for retail pharmacy follows with the trend of “Internet + drug circulation” and complies with the rules of reasonable medical guidance and medication. However, optimizations are required, such as the lack of high-quality medical resources and the urgent need to optimize structure of prescription, and it is still essential to strengthen the management of antibacterial drugs and national essential medicines.

Citation： WANG Jing, XIAO Guirong, SUN Guorui, HUANG Zhen, HU Ming. Evaluation of the current situation and rationality of electronic prescription in retail pharmacies in Chengdu in the context of “Internet + drug circulation”. Chinese Journal of Evidence-Based Medicine, 2020, 20(11): 1274-1279. doi: 10.7507/1672-2531.202006132 Copy

1.	Verma N, Singh H, Khanna D, et al. Classification of drug molecules for oxidative stress signalling pathway. IET Syst Biol, 2019, 13(5): 243-250.
2.	國家食品藥品監督管理局. 藥品流通監督管理辦法, 2007-01-31. Available at: http://www.gov.cn/gongbao/content/2008/content_934082.htm.
3.	國家食品藥品監督管理局. 關于加強零售藥店抗菌藥物銷售監管促進合理用藥的通知, 2003-10-24. Available at: https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20031024010101310.html.
4.	姜明歡, 方宇, 陳文娟, 等. 陜西省藥店憑處方銷售抗生素現狀研究. 中國衛生政策研究, 2013, 6(1): 40-45.
5.	國家衛生計生委等14部門. 遏制細菌耐藥國家行動計劃(2016-2020年), 2016-08-25. Available at: https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20160825120001113.html.
6.	管毓向. 零售藥店處方藥銷售管理存在問題初探. 中國衛生產業, 2020, 17(7): 144-146.
7.	蔡旭鎮, 黃麗娜, 林曉華, 等. 零售藥店安全用藥存在的問題及對策. 齊魯藥事, 2008, 27(8): 503-504.
8.	商務部. 全國藥品流通行業發展規劃(2016-2020年), 2016-12-26. Available at: http://www.mofcom.gov.cn/article/guihua/201612/20161202419508.shtml.
9.	WHO/INRUD. How to investigate drug use in health facility. Selected drug use indicators. Geneva: WHO, 1993: 74.
10.	衛生部. 處方管理辦法, 2006-06-14. Available at: http://www.nhc.gov.cn/fzs/s3576/201808/d71d4735f6c842158d2757fbaa553b80.shtml.
11.	衛生部. 醫院處方點評管理規范(試行), 2010-02-10. Available at: http://www.nhc.gov.cn/wjw/ywfw/201306/094ebc83dddc47b5a4a63ebde7224615.shtml.
12.	Bell DS, Friedman MA. E-prescribing and the medicare modernization act of 2003. Health Aff (Millwood), 2005, 24(5): 1159-1169.
13.	Albarrak AI, Al Rashidi EA, Fatani RK, et al. Assessment of legibility and completeness of handwritten and electronic prescriptions. Saudi Pharm J, 2014, 22(6): 522-527.
14.	Donyai P, O'Grady K, Jacklin A, et al. The effects of electronic prescribing on the quality of prescribing. Br J Clin Pharmacol, 2008, 65(2): 230-237.
15.	Irani Z, Weerakkody V, Molnar A, et al. A user satisfaction study of the NHS online prescription prepayment certificate. Health Policy Technol, 2014, 3(3): 176-184.
16.	邱皓. 北京市某社區衛生服務中心處方點評結果分析. 中國藥事, 2019, 33(12): 1469-1472.
17.	黃猛. 我院2018年門診處方點評及不合格處方原因分析. 臨床醫藥文獻電子雜志, 2019, 6(60): 172-173.
18.	Isah AO, Ross-Degnan D, Quick J, et al. The development of standard values for the WHO drug use prescribing indicators. Geneva: WHO, 1997.
19.	Dumoulin J, Kaddar M, Velásquez G. Guide to drug financing mechanisms. Geneva: WHO, 1998.
20.	米源, 朱星月, 田燕, 等. 20家基層醫療機構合理用藥指標及處方行為研究. 中國藥事, 2017, 31(7): 795-801.
21.	朱星月, 田燕, 周乃彤, 等. 四川省各級醫療機構的門診用藥指標實證研究. 藥學實踐雜志, 2018, 36(1): 40-45.
22.	WHO. Guide to drug financing mechanisms. Geneva: WHO, 1998: 64.
23.	國家衛生健康委. 中國抗菌藥物管理和細菌耐藥現狀報告(2016-2018年), 2019-04-21. Available at: http://www.nhc.gov.cn/yzygj/s3594/201904/1b5a42f0e326487295b260c813da9b0e.shtml.
24.	成都市食品藥品監督管理局. 成都市食品藥品監督管理局關于在全市藥品零售連鎖企業中推進電子處方試點工作的通知, 2016-09-20. Available at: http://scjg.chengdu.gov.cn/cdscjgj/c133654/2016-12/05/content_442e1f8c0bf94c73a83897f9cc17a3ee.shtml.
25.	國家衛生健康委. 關于印發抗菌藥物臨床應用指導原則(2015年版)的通知, 2015-07-24. Available at: http://www.nhc.gov.cn/yzygj/s3593/201508/c18e1014de6c45ed9f6f9d592b43db42.shtml.
26.	Harris AM, Hicks LA, Qaseem A, et al. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American college of physicians and the centers for disease control and prevention. Ann Intern Med, 2016, 164(6): 425-434.

1. Verma N, Singh H, Khanna D, et al. Classification of drug molecules for oxidative stress signalling pathway. IET Syst Biol, 2019, 13(5): 243-250.
2. 國家食品藥品監督管理局. 藥品流通監督管理辦法, 2007-01-31. Available at: http://www.gov.cn/gongbao/content/2008/content_934082.htm.
3. 國家食品藥品監督管理局. 關于加強零售藥店抗菌藥物銷售監管促進合理用藥的通知, 2003-10-24. Available at: https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20031024010101310.html.
4. 姜明歡, 方宇, 陳文娟, 等. 陜西省藥店憑處方銷售抗生素現狀研究. 中國衛生政策研究, 2013, 6(1): 40-45.
5. 國家衛生計生委等14部門. 遏制細菌耐藥國家行動計劃(2016-2020年), 2016-08-25. Available at: https://www.nmpa.gov.cn/xxgk/fgwj/gzwj/gzwjyp/20160825120001113.html.
6. 管毓向. 零售藥店處方藥銷售管理存在問題初探. 中國衛生產業, 2020, 17(7): 144-146.
7. 蔡旭鎮, 黃麗娜, 林曉華, 等. 零售藥店安全用藥存在的問題及對策. 齊魯藥事, 2008, 27(8): 503-504.
8. 商務部. 全國藥品流通行業發展規劃(2016-2020年), 2016-12-26. Available at: http://www.mofcom.gov.cn/article/guihua/201612/20161202419508.shtml.
9. WHO/INRUD. How to investigate drug use in health facility. Selected drug use indicators. Geneva: WHO, 1993: 74.
10. 衛生部. 處方管理辦法, 2006-06-14. Available at: http://www.nhc.gov.cn/fzs/s3576/201808/d71d4735f6c842158d2757fbaa553b80.shtml.
11. 衛生部. 醫院處方點評管理規范(試行), 2010-02-10. Available at: http://www.nhc.gov.cn/wjw/ywfw/201306/094ebc83dddc47b5a4a63ebde7224615.shtml.
12. Bell DS, Friedman MA. E-prescribing and the medicare modernization act of 2003. Health Aff (Millwood), 2005, 24(5): 1159-1169.
13. Albarrak AI, Al Rashidi EA, Fatani RK, et al. Assessment of legibility and completeness of handwritten and electronic prescriptions. Saudi Pharm J, 2014, 22(6): 522-527.
14. Donyai P, O'Grady K, Jacklin A, et al. The effects of electronic prescribing on the quality of prescribing. Br J Clin Pharmacol, 2008, 65(2): 230-237.
15. Irani Z, Weerakkody V, Molnar A, et al. A user satisfaction study of the NHS online prescription prepayment certificate. Health Policy Technol, 2014, 3(3): 176-184.
16. 邱皓. 北京市某社區衛生服務中心處方點評結果分析. 中國藥事, 2019, 33(12): 1469-1472.
17. 黃猛. 我院2018年門診處方點評及不合格處方原因分析. 臨床醫藥文獻電子雜志, 2019, 6(60): 172-173.
18. Isah AO, Ross-Degnan D, Quick J, et al. The development of standard values for the WHO drug use prescribing indicators. Geneva: WHO, 1997.
19. Dumoulin J, Kaddar M, Velásquez G. Guide to drug financing mechanisms. Geneva: WHO, 1998.
20. 米源, 朱星月, 田燕, 等. 20家基層醫療機構合理用藥指標及處方行為研究. 中國藥事, 2017, 31(7): 795-801.
21. 朱星月, 田燕, 周乃彤, 等. 四川省各級醫療機構的門診用藥指標實證研究. 藥學實踐雜志, 2018, 36(1): 40-45.
22. WHO. Guide to drug financing mechanisms. Geneva: WHO, 1998: 64.
23. 國家衛生健康委. 中國抗菌藥物管理和細菌耐藥現狀報告(2016-2018年), 2019-04-21. Available at: http://www.nhc.gov.cn/yzygj/s3594/201904/1b5a42f0e326487295b260c813da9b0e.shtml.
24. 成都市食品藥品監督管理局. 成都市食品藥品監督管理局關于在全市藥品零售連鎖企業中推進電子處方試點工作的通知, 2016-09-20. Available at: http://scjg.chengdu.gov.cn/cdscjgj/c133654/2016-12/05/content_442e1f8c0bf94c73a83897f9cc17a3ee.shtml.
25. 國家衛生健康委. 關于印發抗菌藥物臨床應用指導原則(2015年版)的通知, 2015-07-24. Available at: http://www.nhc.gov.cn/yzygj/s3593/201508/c18e1014de6c45ed9f6f9d592b43db42.shtml.
26. Harris AM, Hicks LA, Qaseem A, et al. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American college of physicians and the centers for disease control and prevention. Ann Intern Med, 2016, 164(6): 425-434.

Previous Article
Analysis on the allocation and equity of medical resources in the five provinces in Northwest China from 2006 to 2017
Next Article
Epidemiological research on inpatients with skin cancer in China

Chinese Journal of Evidence-Based Medicine

Evaluation of the current situation and rationality of electronic prescription in retail pharmacies in Chengdu in the context of “Internet + drug circulation”

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content